stockrow
Friday 6 November 2026
Export DHR’s income statement to Excel — free account
Danaher Corporation
DHR Healthcare Diagnostics & Research
Danaher Corporation’s revenue for fiscal 2025 (year ended December 2025) was $24.6 billion, up 2.90% from fiscal 2024.
- Revenue
- +8.28%
- EPS
- +36.7%
- Free cash flow
- +19.1%
- Total debt
- +44.9%
Quarter to September 2026, against a year earlier
229.63
3.29
+1.45%
Follow DHR
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
6 | 6 | 6 | 6 |
+8 more TTM periods Free account |
| 8.27% | 7.63% | 7.11% | 7.08% | ||
| 5.00% | 4.60% | 4.54% | 4.49% | ||
ROIC |
4.51% | 4.37% | 4.59% | 4.42% | |
Return on Tangible Assets |
37.63% | 36.07% | 30.89% | 31.48% | |
Average Days of Receivables |
58.81 | 57.64 | 56.26 | 58.13 | |
Free Cash Flow per Share |
8.17 | 7.78 | 7.51 | 7.43 | |
Free Cash Flow |
5,751.00 | 5,489.00 | 5,318.00 | 5,293.00 | |
Capital Expenditures |
(1,108.00) | (1,146.00) | (1,121.00) | (1,123.00) | |
| Other line items | |||||
Cash ROIC |
6.87% | 6.69% | 6.98% | 7.00% | |
Accounts Receivable Turnover |
6.50 | 6.67 | 6.77 | 6.60 | |
Accounts Payable Turnover |
6.16 | 5.87 | 5.79 | 5.59 | |
Inventory Turnover |
3.65 | 3.50 | 3.96 | 4.17 | |
Average Days of Payables |
59.97 | 63.85 | 64.21 | 67.00 | |
Days of Inventory on Hand |
107.89 | 114.24 | 93.55 | 90.44 | |
Tax Rate |
(0.11) | (0.16) | (0.15) | (0.15) | |
Research and Development Expense of Revenue |
6.52% | 6.43% | 6.48% | 6.50% | |
Selling, General and Administrative Expense of Revenue |
31.70% | 31.66% | 33.24% | 33.52% | |
Share Based Compensation of Revenue |
1.28% | 1.18% | 1.19% | 1.21% | |
Interest Coverage |
14.49 | 17.56 | 18.59 | 17.70 | |
Operating CF/Net income |
1.58 | 1.66 | 1.75 | 1.78 | |
Depreciation/Fixed assets |
0.48 | 0.44 | 0.45 | 0.44 | |
Capex/Depreciation |
(0.40) | (0.44) | (0.45) | (0.46) | |
Revenue per Share |
36.39 | 35.60 | 35.00 | 34.47 | |
Operating CF per Share |
9.75 | 9.41 | 9.10 | 9.00 | |
Capex per Share |
(1.57) | (1.62) | (1.58) | (1.58) | |
Capex to Sales |
0.04 | 0.05 | 0.05 | 0.05 |
Columns are period end dates · fundamentals updated 2 Nov 2026